98 related articles for article (PubMed ID: 6872338)
1. Attachment of [35S]cysteine to the labile site of the third component of complement via the alternative pathway.
Rutherford CJ; Alper CA; Rosen FS; Babior BM
Clin Immunol Immunopathol; 1983 Jan; 26(1):76-82. PubMed ID: 6872338
[TBL] [Abstract][Full Text] [Related]
2. Covalent binding of [35S]cysteine to the labile binding site of the third component of complement: a physiological approach.
Rutherford CJ; Jenkins DR
Clin Immunol Immunopathol; 1985 Oct; 37(1):77-82. PubMed ID: 4028522
[TBL] [Abstract][Full Text] [Related]
3. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
[TBL] [Abstract][Full Text] [Related]
4. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
5. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.
Pangburn MK; Müller-Eberhard HJ
Ann N Y Acad Sci; 1983; 421():291-8. PubMed ID: 6586103
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin binds to complement-coated agarose beads and increases their association to mouse macrophages.
Johnson E; Gauperaa T; Eskeland T
Scand J Immunol; 1985 Sep; 22(3):315-20. PubMed ID: 3876600
[TBL] [Abstract][Full Text] [Related]
7. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
[TBL] [Abstract][Full Text] [Related]
8. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
Johnson E; Eskeland T; Bertheussen K
Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the third component of human complement (C3) with tumour cells: evidence for presence of C3b acceptor sites and direct activation of C3 by tumour cells.
Daveau M; Fontaine M; Gilbert D
Ann Immunol (Paris); 1981; 132C(3):339-50. PubMed ID: 7332319
[TBL] [Abstract][Full Text] [Related]
10. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
Gadd KJ; Reid KB
Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
[TBL] [Abstract][Full Text] [Related]
12. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).
Belew PW; Rosenberg EW; Jennings BR
Mycopathologia; 1980 Mar; 70(3):187-91. PubMed ID: 6900183
[TBL] [Abstract][Full Text] [Related]
13. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
Winkelstein JA; Abramovitz AS; Tomasz A
J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
[No Abstract] [Full Text] [Related]
14. Complement's alternate pathway.
Ward AN
Hosp Pract; 1979 Jun; 14(6):24. PubMed ID: 447326
[No Abstract] [Full Text] [Related]
15. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
Pangburn MK; Schreiber RD; Müller-Eberhard HJ
J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
[TBL] [Abstract][Full Text] [Related]
16. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
Sármay G; Ramos OF; Klein E; Kai C; Gergely J
Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
[TBL] [Abstract][Full Text] [Related]
17. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
18. Volcanic ash and human complement.
Olenchock SA; Mull JC
Life Sci; 1981 Feb; 28(7):791-4. PubMed ID: 6262591
[No Abstract] [Full Text] [Related]
19. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
[No Abstract] [Full Text] [Related]
20. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
Reed SL; Keene WE; McKerrow JH; Gigli I
J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]